C Norman Coleman
Overview
Explore the profile of C Norman Coleman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
6584
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim M, Mehta M, Smart D, Steeg P, Hong J, Espey M, et al.
Lancet Oncol
. 2023 Aug;
24(8):e344-e354.
PMID: 37541280
Brain metastases are an increasing global public health concern, even as survival rates improve for patients with metastatic disease. Both metastases and the sequelae of their treatment are key determinants...
12.
Martello S, Bylicky M, Shankavaram U, May J, Chopra S, Sproull M, et al.
Radiat Res
. 2023 Aug;
200(3):266-280.
PMID: 37527359
Whole- or partial-body exposure to ionizing radiation damages major organ systems, leading to dysfunction on both acute and chronic timescales. Radiation medical countermeasures can mitigate acute damages and may delay...
13.
Aruah S, Chidebe R, Orjiakor T, Uba F, Shagaya U, Ugwanyi C, et al.
JCO Glob Oncol
. 2023 Jun;
9:e2200406.
PMID: 37348033
Purpose: Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in...
14.
Aryankalayil M, Bylicky M, Chopra S, Dalo J, Scott K, Ueda Y, et al.
Cytogenet Genome Res
. 2023 Jun;
163(3-4):103-109.
PMID: 37285811
Radiation-related normal tissue injury sustained during cancer radiotherapy or in a radiological or mass casualty nuclear incident is a major health concern. Reducing the risk and mitigating consequences of radiation...
15.
Galluzzi L, Aryankalayil M, Coleman C, Formenti S
Nat Rev Clin Oncol
. 2023 Jun;
20(8):543-557.
PMID: 37280366
Immunotherapy has revolutionized the clinical management of many malignancies but is infrequently associated with durable objective responses when used as a standalone treatment approach, calling for the development of combinatorial...
16.
Aryankalayil M, Bylicky M, Martello S, Chopra S, Sproull M, May J, et al.
Int J Radiat Biol
. 2023 May;
99(11):1702-1715.
PMID: 37212632
Purpose: Previous research has highlighted the impact of radiation damage, with cancer patients developing acute disorders including radiation induced pneumonitis or chronic disorders including pulmonary fibrosis months after radiation therapy...
17.
Capala J, Hong J, Vikram B, Coleman C
Cancer Biother Radiopharm
. 2023 Apr;
38(3):141-142.
PMID: 37023402
No abstract available.
18.
Prasanna P, Aryankalayil M, Citrin D, Coleman C
Int J Radiat Biol
. 2023 Feb;
99(7):1027-1036.
PMID: 36763093
Purpose: Progressive, irreversible radiation-induced pulmonary fibrosis (RIPF) is a clinically significant intermediate- to a late-occurring side effect of radiotherapy. Known mechanisms of RIPF include oxidative stress-induced activation of TGF-β with...
19.
Aryankalayil M, Bylicky M, Martello S, Chopra S, Sproull M, May J, et al.
Sci Rep
. 2023 Jan;
13(1):200.
PMID: 36604457
Radiation injury from medical, accidental, or intentional sources can induce acute and long-term hepatic dysregulation, fibrosis, and cancer. This long-term hepatic dysregulation decreases quality of life and may lead to...
20.
Ige T, Lewis P, Shelley C, Pistenmaa D, Coleman C, Aggarwal A, et al.
J Cancer Policy
. 2022 Dec;
35:100372.
PMID: 36512899
Background: Access to high quality radiotherapy (RT) continues to be a major issue across Africa with Africa having just 34% of its optimal capacity. Methods: We co-developed a survey with...